Carmen J Brito Medina, MD
Psychiatry · Bayamon, PRNPI 1922203629
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Johnson & Johnson at 45.7% of the total. 2025 is the largest year on record at $394, 4.2 times the $93 reported in 2019.
Across 32 payments — averaging $34.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$498
- AbbVie$334
- E.r. Squibb & Sons, L.L.C.$98
- Sunovion Pharmaceuticals Inc.$73
- Takeda Pharmaceuticals U.S.A., Inc.$40
- Harmony Biosciences LLC$25
- plus $23 from 1 others
What the payments were for
- Food & beverage$1,091100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $498 |
| AbbVie | 11 | $334 |
| E.r. Squibb & Sons, L.L.C. | 4 | $98 |
| Sunovion Pharmaceuticals Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Harmony Biosciences LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$125
- VRAYLAR$100
How this compares
$1,091 in reported general payments places this provider in the 85th percentile of 312 psychiatry providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estazolam | 172 | $10,919 |
| Clonazepam | 731 | $8,476 |
| Lorazepam | 524 | $5,608 |
| Temazepam | 457 | $4,012 |
| Clorazepate Dipotassium | 53 | $3,630 |
| Bupropion XlBupropion Hcl | 174 | $3,090 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 28 | $2,823 |
| Sertraline Hcl | 506 | $2,798 |
| Quetiapine Fumarate | 359 | $2,728 |
| Duloxetine Hcl | 124 | $2,713 |
| Escitalopram Oxalate | 335 | $2,574 |
| Trazodone Hcl | 311 | $2,276 |
| Mirtazapine | 192 | $2,214 |
| Zolpidem Tartrate | 144 | $1,389 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 108 | $1,328 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Bayamon
- Eric Martinez ColonBayamon$2K
- Carmen SanzBayamon$2K
- Caroline ToroBayamon$2K
- Mayra Abelleira MartinezBayamon$846
- Mary PerezBayamon$828
- Ileana FumeroSan Juan$128K
- Osvaldo CaroCaguas$101K
- Ivonne VicenteSan Juan$49K
- Jose Alonso AlonsoSan Juan$46K
- Maria ColladoJuncos$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.